Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 7Cholangiocarcinoma 5Neoplasms 2Jaundice 2Biliary Tract Neoplasms 2Bile Duct Neoplasms 2Pancreatic Cancer Metastatic to Liver 1Klatskin Tumor 1Gastrointestinal Neoplasms 1Gallbladder Neoplasms 1Fistula 1Disease 1Cholestasis 1

Interventions

Radiofrequency Ablation 1Gemcitabine 1Endoscopic Ultrasound-Guided Fine Needle Aspiration 1Cholangiopancreatography, Endoscopic Retrograde 1Albumin-Bound Paclitaxel 13-(2-(2-tert-butylphenylaminooxalyl)aminopropionylamino)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cholestasis × Cholangiopancreatography, Endoscopic Retrograde × Clear all
NCT01356030 2013-07-09

Endoscopic Ultrasound Versus Endoscopic Retrograde Cholangiopancreatography (ERCP) Tissue Sampling for the Diagnosis of Suspected Pancreatico-Biliary Cancer

California Pacific Medical Center Research Institute

Phase NA Completed
51 enrolled

Cholestasis, Jaundice

Data powered by HemOnc (CC BY 4.0) Colophon âš¡